Changchun High-tech Industry (Group)Inc.

Changchun High-tech Industry (Group)Inc. (CCHT, stock code 000661) is a leading domestic biological medicine field have a certain technical advantages of the listed company, always adhere to the implementation of the pharmaceutical industry is given priority to, the real estate industry is complementary industrial strategy, in line with the "stock do do the foot, incremental" development principles, based on the highly marketable mechanism, the process of international project cooperation, To build five development platforms for genetic engineering drugs, new vaccines, antibody drugs, high-end chemical drugs and modern traditional Chinese medicine in the pharmaceutical industry. The company's subsidiaries include Changchun Kinsair Pharmaceutical Co., LTD., Changchun Baike Biotechnology Co., LTD. And other enterprises. Changchun Gaoxin and Anvotek established a joint venture company, aiming to develop, produce and sell high-quality biosimilar products for domestic and foreign markets, and build an international bioindustry platform for monoclonal antibodies.

Icelandic biopharmaceutical company Alvotech (Alvotech.hf)

Alvotech (Alvotech. Hf) is a famous enterprises focus on antibody biological medicine like Iceland.It was listed on NASDAQ in June 2022 and mainly engaged in biological medicine research and development and production of similar business, has a world-class production, research and development in Iceland and detect factory, plumbing equipment and r&d investment as much as $500 million, has now developed a series of the world's leading biological medicine similar projects and has a worldwide sales network. Through the joint venture with Changchun Hi-Tech, Anvortec will combine the advanced biopharmacological expertise and management experience of Iceland Anvortec with China, the second largest market in the world, and benefit the people of China and the world.

Alvotech & CCHT Biopharmaceutical Co., Ltd. (CAHT)

CAHT is committed to providing medical institutions around the world with a continuous supply of high-end biological drugs that patients can afford. The company's current products are mainly used in the treatment of autoimmune diseases, ophthalmic diseases, osteoporosis and anti-tumor. According to the EMA NMPA, the FDA and the European Union GMP standard, high-end bio-pharmaceutical industrial production base, the company based on its own development and cooperative innovation, with the domestic and foreign well-known pharmaceutical companies to establish strategic cooperation in many fields, world-class standard chemical plant is completed in addition to meet the demand of production and sales, also can undertake the CDMO business of domestic and international, Supply China and the global market for large-scale sales and production needs.